RxDoctor Payments Data

Charles Beavers, MD

Anatomic Pathology & Clinical Pathology · Memphis, TNNPI 1235371691

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,459 of the $1,921 with a category attached, or 75.9%. Werfen USA LLC accounts for 89.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $1,751 and has fallen 98.0% since, to $35 in 2025. Among anatomic pathology & clinical pathology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,921in general payments, 2019–2025

Across 15 payments — averaging $128.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Werfen USA LLC$2K
  • Hemosonics LLC$64
  • Biofire Diagnostics, LLC$40
  • Johnson & Johnson$35
  • Grifols Diagnostic Solutions, Inc.$32
  • Oxford Immunotec USA Inc$29
$46,000in research payments, 2019–2025

Across 1 payment — averaging $46,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Diagnostica Stago, Inc$46K

What the payments were for

  • Speaking & faculty fees$402%
  • Travel & lodging$1,45976%
  • Food & beverage$42322%

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,921 in reported general payments places this provider in the 90th percentile of 234 anatomic pathology & clinical pathology providers in Tennessee.

See all anatomic pathology & clinical pathology providers in Tennessee

Medicare billing

Part B allowed, 2024
$109,007
Medicare patients
1,835
Services billed
10,591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →